United States · Series D startup

Who invested in Click Therapeutics

3 rounds we have observed, with the 5 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Raised 1 month ago

Funding summaryUpdated 5 Nov 2026

$149Mraised across 3 rounds since 2025, from 4 sources

$49MSeries C$50MSeries D$50MRound
Latest round
Round, $50MOct 2026
Biggest round
$50MSeries D · May 2026
Investors
5 (1 led)
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2026
$49MSeries C$50MSeries D$50MRound
First round
Series C, $49M
Mar 2025
Biggest round
$50M
Series D · May 2026
Usual gap between rounds
14 months
the median of 2

The rounds

  1. Oct 2026
    Round$50M

    No investor was named in the report.

    Filed with the SEC (Form D); no report of this raise yetSEC filing: $50M sold, first sale Oct 2026

  2. May 2026
    Series D$50M2 new2 returning

    Reported by Revelation Partners and 1 other

  3. Mar 2025
    Series C$49M3 new

    Source recordedSEC filing: $49M sold, first sale Mar 2025

Founders and team

From Click Therapeutics's own website: 1 founder, 8 on the team.

David Benshoof KleinFounder & CEO
  • Austin SpeierChief Strategy Officer
  • Randall StanickyChief Financial Officer
  • Rich DeNunzioChief Commercial Officer
  • Dan RimmVP of Product
  • Daniel RimmHead of Product
  • Ritesh ManchandaHead of Engineering
  • Sarah JacksonHead of Business Development and Alliance Management
  • Gosia MachniewskaAssociate Design Director

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Series C2025Series D2026Round2026SVB CapitalSanofiBoehringer IngelheimLAccelHSBC

Everyone who backed them

SVB CapitalVC firm2rounds
SanofiInvestment firm2rounds
Boehringer IngelheimVC firm1round, led 1
AccelVC firm1round
HSBCGrowth equity1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

These 4 firms list Click Therapeutics as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.

Hikma VenturesCorporate VCPer its own site
AccelmedVC firmPer its own site
Supernode VenturesVC firmPer its own site
Health Catalyst CapitalPrivate equityPer its own site

Quick answers about Click Therapeutics

Who invested in Click Therapeutics?

Click Therapeutics's investors include SVB Capital, Sanofi, Boehringer Ingelheim, Accel and HSBC.

How much has Click Therapeutics raised?

Click Therapeutics has raised $149M across 3 rounds since 2025.

When did Click Therapeutics last raise?

Click Therapeutics's most recent round, $50M, was in Oct 2026.

What was Click Therapeutics's biggest round?

Click Therapeutics's largest round on record is $50M (Series D), in May 2026, led by Boehringer Ingelheim.

Who backed Click Therapeutics first?

Click Therapeutics's first round on record, in Mar 2025, was backed by SVB Capital, HSBC and Sanofi.

What stage is Click Therapeutics at?

Click Therapeutics's latest named round is a Series D, in May 2026.

Where is Click Therapeutics based?

Click Therapeutics is based in the United States.

Who led Click Therapeutics's rounds?

Boehringer Ingelheim led the Series D in 2026.

Companies like Click Therapeutics

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.